Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility

Back

EHRA Premium Access

Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility

Session: Atrial fibrillation: ablation 3

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor V. Kanthasamy (London, GB)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Vijayabharathy Kanthasamy

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Pulmonary vein isolation using pulsed field ablation versus high-power-short-duration radiofrequency ablation for paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up.

Speaker: Professor N. Reinsch (Essen, DE)

Heart rate dynamics after pulmonary vein isolation: pulsed-field vs. radiofrequency ablation

Speaker: Doctor C. Valeriano (Barcelona, ES)

Procedural and outcome impact of body mass index on pulsed field ablation of atrial fibrillation: insights from the EU-PORIA Registry

Speaker: Doctor A. Telesca (Rome, IT)

Impact of age on the management and prognosis of oesophageal fistula after atrial fibrillation ablation - a subanalysis of the worldwide POTTER-AF study

Speaker: Doctor S. Popescu (Luebeck, DE)

Multielectrode catheter-based pulsed electric field versus cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis

Speaker: Doctor G. Vetta (Brussels, BE)

Access the full session

Atrial fibrillation: ablation 3

Speakers: Doctor V. Kanthasamy, Professor N. Reinsch, Doctor C. Valeriano, Doctor A. Telesca, Doctor S. Popescu...

Access

Video

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources